Walleye Capital
NARI

Walleye Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Walleye Capital’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,058
Closed -$309K – 5364
2024
Q4 		$309K Buy
+6,058
New +$298K ﹤0.01% 3399
2024
Q3 		– Sell
-13,166
Closed -$634K – 6019
2024
Q2 		$634K Buy
+13,166
New +$584K ﹤0.01% 3295
2022
Q4 		– Sell
-10,953
Closed -$796K – 3723
2022
Q3 		$796K Buy
10,953
+2,939
+37% +$219K 0.02% 1140
2022
Q2 		$545K Buy
8,014
+2,952
+58% +$212K 0.02% 979
2022
Q1 		$459K Buy
+5,062
New +$414K 0.01% 1056
2021
Q2 		– Sell
-32,847
Closed -$3.52K – 1545
2021
Q1 		$3.52K Buy
32,847
+7,283
+28% +$756K 0.2% 77
2020
Q4 		$2.23K Buy
25,564
+21,039
+465% +$1.49M 0.15% 109
2020
Q3 		$312K Buy
+4,525
New +$291K 0.03% 496

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Walleye Capital's NARI Position: Q1 2025 in Review

Walleye Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 6,058 shares — an estimated $309K sold.

Walleye Capital first reported a position in NARI in Q3 2020 and held it in 8 quarters. The position peaked at $796K in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Walleye Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 6,058 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $309K.
  • Walleye Capital first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Walleye Capital's Inari Medical, Inc. Common Stock position peaked at $796K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.